Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet (Q46779281)

25 December 2017

title

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet (English)

1 reference

25 December 2017

0 references

0 references

4

1 reference

25 December 2017

Angelo A. Izzo

6

1 reference

25 December 2017

Vincenzo Di Marzo

7

1 reference

25 December 2017

Katarzyna Starowicz-Bubak

object named as

Katarzyna M Starowicz

1

0 references

author name string

Luigia Cristino

2

1 reference

25 December 2017

Isabel Matias

3

1 reference

25 December 2017

Alessandro Racioppi

5

1 reference

25 December 2017

publication date

17 January 2008

1 reference

25 December 2017

published in

Obesity

1 reference

25 December 2017

volume

16

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

553-565

1 reference

25 December 2017

Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Pharmacological actions of cannabinoids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Molecular characterization of a phospholipase D generating anandamide and its congeners

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Brain monoglyceride lipase participating in endocannabinoid inactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Activation of the peripheral endocannabinoid system in human obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Endocannabinoids and the control of energy balance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Endocannabinoids in adipocytes during differentiation and their role in glucose uptake.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Endocannabinoid control of food intake and energy balance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Leptin-regulated endocannabinoids are involved in maintaining food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet beta cells modulates insulin secretion in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Anandamide and vanilloid TRPV1 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Expression and functional activity of PPARgamma in pancreatic beta cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Peroxisome proliferator-activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Role of cannabinoid CB2 receptors in glucose homeostasis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

The effect of a fat-enriched diet on the pattern of distribution of pancreatic islet cells in the C57BL/6J mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Role of cyclooxygenase-2 in cytokine-induced beta-cell dysfunction and damage by isolated rat and human islets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Early changes in insulin secretion and action induced by high-fat diet are related to a decreased sympathetic tone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Impaired insulin action in subcutaneous adipocytes from women with visceral obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Human adipose tissue cannabinoid receptor 1 gene expression is not related to fat cell function or adiponectin level

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Abdominal obesity and metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

Identification of endocannabinoids and related compounds in human fat cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.106

31 March 2020

Identifiers

DOI

10.1038/OBY.2007.106

1 reference

25 December 2017

1 reference

25 December 2017